Menu
Subscribe to our Email Alerts
About Us
Island at a glance
Board
Key Management
Scientific Advisory Board
Collaborations
Science
About ISLA-101
Scientific Publications
Drug repurposing and benefits
Disease and drug terms explained
Investor Centre
Investor Welcome
Clinical programme
ASX Announcements
Presentations
Prospectus
Financial Reports
Share Price Information
Shareholder Services
Investor Fact Sheet
Corporate Governance
Corporate Directory
International Investors
Research Coverage
AGM
Media
News
IslandWatch Newsletter
Contact
Contact Us
Subscribe for Email Alerts
Media
Media
>
News
News
IslandWatch Newsletter
News
Filter by Year:
2024
2023
2022
2021
2020
2-Dec-2024
Ausbiz: Island Pharma progressing in its fight against dengue
30-Nov-2024
BIOSHARES: Island Pharmaceuticals Achieves Endpoints in Phase 2a Study in Dengue Fever
28-Nov-2024
Webinar recording: Island Phase 2a readout investor briefing
27-Nov-2024
Webinar: Island CEO on major milestone of ISLA-101 Phase 2a trial in dengue
27-Nov-2024
The Australian: Island Pharmaceuticals Trial success with dengue fever drug
27-Nov-2024
Webinar recording: Island Phase 2a readout investor briefing and Q&A
6-Nov-2024
The Australian: Island Pharmaceuticals’ two-pronged plan to put the mozz on dengue fever
15-Oct-2024
The Australian: Pitt Street Research says Island Pharmaceuticals should be worth up to 115% more
15-Oct-2024
Bioshares: Island Pharmaceuticals Shares Surge on Trial Start and Capital Raise
8-Oct-2024
Island Pharmaceuticals Investor Update - October 2024
1
2
3
4
Next
.png){kind=logo}
